Genfit SA (GNFT)

4.535 -0.68 (-12.96%) USD  |  NASDAQ  |  Nov 14, 16:00
4.59 +0.06 (+1.21%) After-Hours: 07:33
More

Genfit Cash and Short Term Investments (Quarterly): 85.99M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2009. Upgrade now.
Date Value
June 30, 2024 66.08M
December 31, 2023 85.99M
June 30, 2023 121.53M
December 31, 2022 150.73M
June 30, 2022 218.44M
December 31, 2021 292.97M
June 30, 2021 124.21M
December 31, 2020 210.36M
June 30, 2020 253.86M
December 31, 2019 310.00M
June 30, 2019 320.54M
June 30, 2019 320.54M
December 31, 2018 237.06M
June 30, 2018 275.19M
June 30, 2018 275.19M
December 31, 2017 328.50M
June 30, 2017 144.46M
June 30, 2017 144.46M
December 31, 2016 160.98M
June 30, 2016 105.27M
Date Value
June 30, 2016 105.27M
December 31, 2015 65.72M
June 30, 2015 73.25M
June 30, 2015 73.25M
December 31, 2014 92.42M
June 30, 2014 90.01M
June 30, 2014 90.01M
December 31, 2013 28.89M
June 30, 2013 38.26M
June 30, 2013 38.26M
December 31, 2012 8.337M
June 30, 2012 13.76M
June 30, 2012 13.76M
December 31, 2011 16.59M
June 30, 2011 14.75M
June 30, 2011 14.75M
December 31, 2010 18.54M
June 30, 2010 22.02M
December 31, 2009 24.93M
June 30, 2009 29.00M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

66.08M
Minimum
Jun 2024
310.00M
Maximum
Dec 2019
183.42M
Average
180.54M
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Edap TMS SA 28.46M
Cellectis SA 260.89M
Ascendis Pharma AS 277.30M
Adaptimmune Therapeutics PLC 214.79M
Akari Therapeutics PLC 4.177M